Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting System-Reference-Cited by-同舟云学术

Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting System

Published:2016-09 Issue:3 Volume:90 Page:706-707
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Jhaveri Kenar D.,Sakhiya Vipulbhai,Wanchoo Rimda,Ross Daniel,Fishbane Steven

Publisher

Elsevier BV

Subject

Nephrology

Reference4 articles.

1. National Cancer Institute Targeted Therapy. Available at: http://www.cancer.gov/about-cancer/treatment/types/targeted-therapies. Accessed May 1, 2016.

2. Renal effects of anti-angiogenesis therapy: update for the internist;Gurevich;Am J Med,2009

3. Nephrotoxicity of the BRAF inhibitors vermurafenib anddabrafenib;Jhaveri;JAMA Oncol,2015

4. Shirali A, Perazella MA, Gettinger S. Association of acute interstitial nephritis with programmed cell death (PD)-1 inhibitor therapy in lung cancer patients [e-pub ahead of print]. Am J Kidney Dis. http://dx.doi.org/10.1053/j.ajkd.2016.02.057, accessed July 8, 2016.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nephrotoxicity of targeted therapy used to treat lung cancer;Frontiers in Immunology;2024-07-04

2. Evaluation of a new score associated with acute kidney injury in patients treated with cisplatin based EXTREME regimen;BMC Cancer;2024-04-02

3. The Current State of Nuclear Nephrology in Modern Medicine;PRILOZI;2023-12-01

4. Acute Oncologic Complications: Clinical–Therapeutic Management in Critical Care and Emergency Departments;Current Oncology;2023-08-02

5. Hypokalemia after rituximab administration in nephrotic syndrome: two case reports;BMC Nephrology;2023-07-18